Synergism of Selective Tumor Vascular Thrombosis and Protease Activated Prodrug

2008 ◽  
Author(s):  
Cheng Liu
Keyword(s):  
Vascular Thrombosis

Current perspectives in antithrombotic therapy

2001 ◽  
Vol 21 (03) ◽  
pp. 82-96 ◽  
Author(s):  
D. Hoppensteadt ◽  
O. Iqbal ◽  
R. L. Bick ◽  
J. Fareed
Keyword(s):  
Blood Coagulation ◽  
Antithrombotic Therapy ◽  
Thrombotic Event ◽  
The United States ◽  
Vascular Thrombosis ◽  
Common Cause ◽  
Coagulation Protein ◽  
Coronary Events ◽  
Platelet Defects

SummaryThrombotic disorders are the most common cause of death in the United States. About two million individuals die each year from an arterial or venous thrombosis or related disorders. About 80% to 90% of all cases of thrombosis can now be defined with respect to cause. Of these, over 50% occur in patients who harbor a congenital or acquired blood coagulation protein or platelet defect which caused the thrombotic event. It is obviously of major importance to define those individuals harboring such a defect as this allows: 1) appropriate antithrombotic therapy to decrease risks of recurrence; 2) determination of the length of time the patient must remain on therapy for secondary prevention; and 3) allow for testing of family members of those harboring a blood coagulation protein or platelet defect which is hereditary (about 50% of all coagulation and platelet defects mentioned above). Aside from mortality, significant additional morbidity occurs from both arterial or venous thrombotic events, including, but not limited to paralysis (non-fatal thrombotic stroke), cardiac disability (repeated coronary events), loss of vision (retinal vascular thrombosis), fetal waste syndrome (placental vascular thrombosis), stasis ulcers and other manifestations of post-phlebitic syndrome, etc.

Novel approach for Recanalization and Limb Saving Following Acute Thrombosis of Upper Limb Arteries in Two Neonates After Congenital Heart Surgery

2020 ◽  
Author(s):  
Jameel Al- Ata ◽  
Gaser Abdelmohsen ◽  
Saud Bahaidarah ◽  
Naif Alkhushi ◽  
Zaher Zaher
Keyword(s):  
Congenital Heart Disease ◽  
Cardiac Output ◽  
Congenital Heart ◽  
Heart Surgery ◽  
Heart Diseases ◽  
Congenital Heart Surgery ◽  
Low Cardiac Output ◽  
Vascular Thrombosis ◽  
Acute Thrombosis ◽  
Novel Approach

IntroductionNeonates with congenital heart disease are at a high risk of vascular thrombosis. Thrombosis may occur due to vascular injury, increased blood viscosity secondary to polycythemia associated with congenital cyanotic heart diseases, or stasis of blood flow associated with low cardiac output (Schmidt B & Andrew M., Pediatrics 1995; 96: 939–943. Veldman A et al.,Vasc Health Risk Manag 2008; 4: 1337–1348).

On postpartum pulmonary embolism

1934 ◽  
Vol 30 (10) ◽  
pp. 1027-1029
Author(s):  
A. I. Petchenko
Keyword(s):  
Pulmonary Embolism ◽  
Blood Flow ◽  
Blood Loss ◽  
Postpartum Period ◽  
Vascular Tone ◽  
Thrombus Formation ◽  
Obstetrics And Gynecology ◽  
Vascular Thrombosis ◽  
Vein Thrombosis

Vascular thrombosis in obstetrics and gynecology is quite common, although not always easy to recognize. In the postpartum period, after many vaginal operations we have massive thrombus formation. Placental vein thrombosis is almost physiological; slowed blood flow, decreased vascular tone after the fetus emerges, blood loss are predisposing moments to thrombosis formation in the postpartum period.

Ocular Vascular Thrombosis Following Tin Ethyl Etiopurpurin (SnET2) Photodynamic Therapy: Time Dependencies

1998 ◽  
Vol 29 (8) ◽  
pp. 663-668
Author(s):  
Darius M Moshfeghi ◽  
Gholam A Peyman ◽  
Andrew A Moshfeghi ◽  
Bahram Khoobehi ◽  
George B Primbs ◽  
...  
Keyword(s):  
Photodynamic Therapy ◽  
Vascular Thrombosis ◽  
Time Dependencies

Aeromonas hydrophila Infection Causing Delayed Vascular Thrombosis in a Nearly Amputated Finger

2007 ◽  
Vol 32 (7) ◽  
pp. 1058-1060
Author(s):  
Fernando A. Herrera ◽  
Karen Horton ◽  
Ahmed Suliman ◽  
Gregory M. Buncke
Keyword(s):  
Aeromonas Hydrophila ◽  
Vascular Thrombosis

Molecular Imaging of Vascular Thrombosis

2014 ◽  
Vol 3 (1) ◽  
pp. 27-36
Author(s):  
Timo Heidt ◽  
Felix Gunther ◽  
Marvin Krohn-Grimberghe ◽  
Karlheinz Peter ◽  
Christoph Bode ◽  
...  
Keyword(s):  
Molecular Imaging ◽  
Vascular Thrombosis

scholarly journals Mean Platelet Volume and Platelet Distribution Width as Markers of Vascular Thrombosis in Type 2 Diabetes Mellitus

2016 ◽  
Vol 50 (3) ◽  
pp. 127-131 ◽  
Author(s):  
M Bhanukumar ◽  
Prasanna KH Ramaswamy ◽  
Naveen K Peddi ◽  
Vineetha B Menon
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Mean Platelet Volume ◽  
Platelet Distribution Width ◽  
Platelet Volume ◽  
Distribution Width ◽  
Vascular Thrombosis ◽  
Type 2 Dm

ABSTRACT Aims The objective of the study was to determine the mean platelet volume (MPV) and platelet distribution width (PDW) in subjects with type 2 diabetes mellitus (type 2 DM) compared to subjects without type 2 DM and their correlation with fasting blood glucose, glycosylated hemoglobin (HbA1c), and duration of type 2 DM respectively. Materials and methods A prospective analytical case—control study was conducted involving 50 subjects with type 2 DM and 50 subjects without type 2 DM. The mean and standard deviation were estimated for both the groups separately and independent Student's “t”-test was used for evaluating the significant difference. The statistical evaluation was carried out at 95% confidence level. Results Mean MPV and PDW in case group was significantly higher compared to control group (p < 0.005). Fasting blood glucose, HbA1c, and duration of type 2 DM did not significantly alter MPV or PDW. Conclusion The study concludes that MPV and PDW are significantly increased in patients with type 2 DM compared to patients without type 2 DM. Platelet volume indices are an important, simple, and cost-effective tool that should be used and explored extensively, especially in countries, such as India, for predicting the possibility of impending acute vascular events in patients with type 2 DM. Clinical significance This analytical method helps us to use MPV and PDW as early markers of vascular thrombosis. How to cite this article Bhanukumar M, Ramaswamy PKH, Peddi NK, Menon VB. Mean Platelet Volume and Platelet Distribution Width as Markers of Vascular Thrombosis in Type 2 Diabetes Mellitus. J Postgrad Med Edu Res 2016;50(3):127-131.

scholarly journals Pulmonary Vascular Thrombosis in COVID-19 Pneumonia

2021 ◽  
Author(s):  
Francesco De Cobelli ◽  
Diego Palumbo ◽  
Fabio Ciceri ◽  
Giovanni Landoni ◽  
Annalisa Ruggeri ◽  
...  
Keyword(s):  
Vascular Thrombosis
Sign in / Sign up

Export Citation Format

Share Document